Atara Biotherapeutics Inc., is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases.
With our lead program receiving marketing authorization in Europe, Atara is the most advanced allogeneic T-cell immunotherapy company and intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical need. Our platform leverages the unique biology of EBV T cells and has the capability to treat a wide range of EBV-associated diseases, or other serious diseases through incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform, which does not require TCR or HLA gene editing, to create a robust pipeline including: tab-cel for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) and other EBV-driven diseases; ATA188, a T-cell immunotherapy targeting EBV antigens as a potential treatment for multiple sclerosis; and multiple next-generation chimeric antigen receptor T-cell (CAR-T) immunotherapies for both solid tumors and hematologic malignancies.
Company Details
- Employees
- 171
- Founded
- -
- Address
- 2380 Conejo Spectrum St,
- Phone
- (650) 278-8930
- of****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- atarabio.com
- Keywords
- biotechnology, immunotherapy, cell therapy, gene therapy, regenerative medicine, T-cells, cytotoxic T lymphocytes, CTLs, allogeneic, off the shelf, cancer, oncology, immuno-oncology, hematology, immunology, autoimmune diseases, multiple sclerosis, MS, Epstein-Barr virus, EBV, post-transplant lymphoproliferative disorder, PTLD, nasopharyngeal carcinoma, Cytomegalovirus, CMV, oncoviruses, bone marrow transplant, stem cell transplant, solid organ transplant, lymphoma, secondary lymphoma, secondary malignancy, lymphoproliferative disorders, EBV lymphoma, Atara Bio, Atara, ATRA, CAR T, solid tumors, Allogeneic CD19 CAR T, Allogeneic EBV CAR T-cell platform, Allogeneic CAR T-cell therapies, progressive multiple sclerosis.
- HQ
- Thousand Oaks, CA
Atara Biotherapeutics Questions
Atara Biotherapeutics's helpline number is (650) 278-8930
Atara Biotherapeutics's website is atarabio.com
Atara Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/atarabio
Atara Biotherapeutics has
171 employees.
View email and phone details for 171
employees at Atara Biotherapeutics.
Atara Biotherapeutics's industry is
Biotechnology Research
Atara Biotherapeutics's top competitors are
Kite Pharma,
Capsida Biotherapeutics,
Regenxbio,
A2 Biotherapeutics, Inc.,
Immunitybio, Inc.,
Cargo Therapeutics,
Poseida Therapeutics, Inc.,
Amgen,
Allogene Therapeutics,
Capricor Therapeutics, Inc..
Atara Biotherapeutics's support email address is office@atarabio.com
Atara Biotherapeutics's categories are Biotechnology Research
Atara Biotherapeutics's founding year is 2012
